3D Global Biotech Inc. (6808.TWO)
TWD 49.15
(-19.82%)
TWD 49.15
(-19.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 324.14 Million TWD | -12.69% |
| 2022 | 371.26 Million TWD | -12.54% |
| 2021 | 424.51 Million TWD | -12.03% |
| 2020 | 482.57 Million TWD | -4.66% |
| 2019 | 506.17 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 515.6 Million TWD | 59.06% |
| 2024 Q2 | 515.6 Million TWD | 0.0% |
| 2023 FY | 324.14 Million TWD | -12.69% |
| 2023 Q1 | 341.29 Million TWD | -8.07% |
| 2023 Q2 | 341.29 Million TWD | 0.0% |
| 2023 Q3 | 324.14 Million TWD | -5.02% |
| 2023 Q4 | 324.14 Million TWD | 0.0% |
| 2022 Q4 | 371.26 Million TWD | 0.0% |
| 2022 Q3 | 371.26 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -153.148% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | 88.826% |
| Level Biotechnology Inc. | 822.67 Million TWD | 60.598% |
| Sagittarius Life Science Corp | 664.72 Million TWD | 51.236% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | 40.93% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 91.676% |
| GlycoNex Incorporation | 1.55 Billion TWD | 79.125% |
| VBI | 452.1 Million TWD | 28.302% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | 72.44% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | 56.698% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | 14.329% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | 71.412% |
| Visgeneer Inc. | 397.17 Million TWD | 18.387% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 91.403% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | 84.986% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | 63.294% |
| Neith Corporation | 192.15 Million TWD | -68.693% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 94.68% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -340.67% |
| Enimmune corporation | 604.82 Million TWD | 46.406% |
| TaiRx, Inc. | 833.74 Million TWD | 61.121% |
| CHO Pharma, Inc. | 3.08 Billion TWD | 89.496% |
| EirGenix Inc. | 11.16 Billion TWD | 97.096% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | 43.443% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | 81.07% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 90.988% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | 69.143% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -7.679% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -22.479% |
| Lukas Biomedical Inc. | 441.19 Million TWD | 26.529% |
| RBC Bioscience Corporation | 753.79 Million TWD | 56.998% |
| BiOptic Inc. | 613.77 Million TWD | 47.188% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | 81.776% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | 72.049% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | 49.733% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 89.565% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -119.117% |
| NaviFUS Corp. | 490.53 Million TWD | 33.919% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | 73.554% |
| Sinew Pharma Inc. | 1.36 Billion TWD | 76.225% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | 38.741% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | 72.09% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | 80.429% |
| AP Biosciences Inc | 890.75 Million TWD | 63.61% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 96.199% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | 75.695% |
| Intech Biopharm Corporation | 2.71 Billion TWD | 88.044% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 97.89% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | 20.989% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | 18.32% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | 84.385% |
| TCI GENE Inc. | 1.16 Billion TWD | 72.199% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -10.037% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | 76.224% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | 65.581% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | 53.59% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 91.802% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 91.52% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | 73.643% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 94.216% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | 69.478% |
| Acepodia, Inc. | 6.81 Billion TWD | 95.246% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 91.529% |